Bio

Publications


2011

Gloria S. Omosa-Manyonyi, Walter Jaoko, OAHOSW, Roselyn Malogo, Jacqueline Nyange PNJN-A, Kirana Bhatt, Bashir Farah MOCSFPPF.  2011.  . Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya. PLoS One. 6(1):e14580.

2008

Walter Jaoko, Frederick N Nakwagala, OAGOMJ, Birungi, Annet Nanvubya FBKBHOSWLM, Wambui Waruingi, Jane Odada MOJIJN-ACK, Emmanuel Mugisha, Patricia Fast CSJGTTCSBBLD, Bruce Johnson, Andrew Muluubya LNPHMB, and Peter Hughes, Tomas Hanke AMMJBPK.  2008.  Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.. Vaccine,. 26(22):2788-95.

2007

4. Karita, Etiennea; Price, M; HE; CE; AS; FL; KA, h; Sanders, Eduard J AO;MO; KM; KN.  2007.  Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS. 21(4):403-408.

2004

6. B M Farah1, S Ogola1, I1 O1 A1 O-M1 J1 G2 BJMOG.  2004.  The use of viral peptides as a quality control for ELISPOT assays in HIV-1 vaccine trials in Kenya., Jul 11-16. International Conference AIDS.. , Bangkok, Thailand
Anzala O, Bashir MF, OOBJJJWGMGOMF.  2004.  CD4 and CD8 T - Lymphocyte distribution among healthy Kenyans enrolling in an HIV vaccine trial., Jul 11-16. International Conference AIDS. . , Bangkok, Thailand

UoN Websites Search